(adsbygoogle = window.adsbygoogle || []).push({}); EU has been in talks with India about a new trade agreement.
Opening up new markets and areas for India within the EU. Making it easier along with less taxes etc etc

However it comes at a cost which would mean India would need to respect EU copyright laws and patents.
Where the problem well India has alot of drug companies which produce drugs based on EU patented drugs.

India has a rep for being "pharmacy of the developing world" this would stop under the new trade deal. Any company who keeps making patented drugs would be taken to court and right now no way nobody can take them to court.
It one of the things the EU is pushing for and has a negative effected.
EU companies line their pockets and remove cheap Indian drugs from the market.

Many poor people across the world depends on these drugs.
Take for example a HIV drug made in india costs per year £120 pounds , branded version £7,000 per year.

I understand it important to protect your product but when companies are making a insane profit it just wrong.
Here my view
The EU companies should reduce their prices and allowed the indian companies to produce said drugs at a reduced rate.
I do know that making drugs costs alot but 7,000 is bit much. They could sell far more and make much more then just pricing people out of the market.
Do you think we should price people out just because we have the knowledge ?

The EU-India Broad-based Trade and Investment Agreement (BTIA) i believe is the name of it

It should be balanced. I support companies raking in large profits because that will encourage them to reinvest into Research and Development and make new drugs. Getting them to cut profits may get them to invest less in R and D as they see no real profit in investing that much overhead. The question here is morality because these drugs can save lives and those who cannot afford it may suffer or die knowing that help was that close. Companies feel the need to price out because that maximizes revenue; drugs aren't like food, not everyone needs it. Therefore, while lowering pricing may get more customers, it may not bring enough in to equal or exceed previous revenue. Companies will not like to switch to a lower revenue stream from a higher revenue stream because we want them to be nice and think globally. The EU will be pushing to protect the rights of big corporations because the more revenue corporations rake in, the more tax dollars. Most of the EU seems to need every dollar it can get nowadays, so they will use what they can to protect people who share their interests. This is like the SOPA internet crackdown over copyright material. The pirated content didn't really slow the movie industry; all it did was, hinder the DVD/Blu-Ray market but the U.S government caught Megaupload execs on a RICO case and handed out sentences worse than ones given to rapists. This example just shows the ridiculous lengths some governments will go to provided enough financial backing. I don't like pricing people out of the market especially since this is the drug market but at the end of the day, only the corporations will be able to allow the manufacture of their products if this "trade deal" goes through.